Property:RefTags
From GxPlex
Raw TAG-ID list for this reference (used for glossary queries).
I
TAG-00048-Sus-ngV ++ TAG-00047-Une-ete ++ TAG-00244-Def-ini ++ TAG-00066-Cau-enh ++ TAG-00331-Une-irk +
U
USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 2.1.32 - 2.1.34 +
TAG-00048-Sus-ngV ++ TAG-00244-Def-ini ++ TAG-00320-Foo-eri ++ TAG-00017-Spo-die +
G
TAG-00048-Sus-ngV ++ TAG-00251-Spo-ezu ++ TAG-00057-Com-deR ++ TAG-00017-Spo-die +
F
FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 R1123-53 +
TAG-00048-Sus-ngV ++ TAG-00251-Spo-ezu ++ TAG-00321-Age-pro ++ TAG-00001-Med-rzn +
G
TAG-00048-Sus-ngV ++ TAG-00251-Spo-ezu ++ TAG-00017-Spo-die ++ TAG-00057-Com-deR +
E
TAG-00048-Sus-ngV ++ TAG-00251-Spo-ezu ++ TAG-00252-Exp-hle ++ TAG-00017-Spo-die ++ TAG-00058-Eur-zne +
TAG-00048-Sus-ngV ++ TAG-00252-Exp-hle ++ TAG-00146-Ref-che ++ TAG-00017-Spo-die ++ TAG-00340-Req-nfo +
G
TAG-00049-Ser-Ver ++ TAG-00017-Spo-die ++ TAG-00057-Com-deR ++ TAG-00043-Goo-tek ++ TAG-00033-Pro-oto +
E
TAG-00049-Ser-Ver ++ TAG-00017-Spo-die ++ TAG-00262-CTI-Kli ++ TAG-00253-Rep-att +
G
GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 D Who should notify +
TAG-00049-Ser-Ver ++ TAG-00017-Spo-die ++ TAG-00148-Con-rsc ++ TAG-00183-Aut-Ver ++ TAG-00111-Agr-chr +
E
EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021 6.4 +
TAG-00049-Ser-Ver ++ TAG-00019-Pri-Prü ++ TAG-00257-Sit-zen ++ TAG-00246-Inv-hte +
G
GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 Appendix I +
TAG-00049-Ser-Ver ++ TAG-00135-Inv-ntr ++ TAG-00324-Med-Age ++ TAG-00142-Mul-ent +
E
EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021 5.1 +
TAG-00049-Ser-Ver ++ TAG-00244-Def-ini ++ TAG-00033-Pro-oto ++ TAG-00329-Saf-lne +
G
GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 D What needs to be reported +
TAG-00049-Ser-Ver ++ TAG-00244-Def-ini ++ TAG-00043-Goo-tek ++ TAG-00033-Pro-oto +
GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 D Investigator/Institution +
TAG-00049-Ser-Ver ++ TAG-00246-Inv-hte ++ TAG-00148-Con-rsc ++ TAG-00151-Sta-rat ++ TAG-00017-Spo-die +
E
EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021 3.2 +
TAG-00049-Ser-Ver ++ TAG-00253-Rep-att ++ TAG-00017-Spo-die +
EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021 4 +
TAG-00049-Ser-Ver ++ TAG-00253-Rep-att ++ TAG-00262-CTI-Kli ++ TAG-00329-Saf-lne +
G
GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 D When should the notification be made +
TAG-00049-Ser-Ver ++ TAG-00253-Rep-att ++ TAG-00148-Con-rsc ++ TAG-00017-Spo-die +
E
EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021 3.1 +
TAG-00049-Ser-Ver ++ TAG-00262-CTI-Kli ++ TAG-00017-Spo-die ++ TAG-00147-Ser-inD ++ TAG-00111-Agr-chr +
EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021 Appendix I +
TAG-00049-Ser-Ver ++ TAG-00327-Exa-spi +
